Objectives: • Discuss the therapeutic options currently being used for COVID-19 • Evaluate some clinical data supporting the use of these drugs • Comment on clinical trials and enrollment
Participants: • Andre Kalil, Professor, University of Nebraska Medical Center, Omaha, NB, USA. Lead Investigator, NIH Clinical Trial for COVId-19 • Miguel A. Martinez, Editor AAC. Professor, AIDS Research Institute-IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
Visit https://aac.asm.org/ to browse issues and/or submit a manuscript.